Intrasalivary gland injection of botulinum toxin type A is known to treat sialorrhea effectively in children with cerebral palsy. However, oral health may be compromised with escalating dose. In this randomized, double-blind, and placebo-controlled pilot trial, the authors aim to determine the therapeutic effect of low-dose, ultrasonography-controlled botulinum toxin type A injection to bilateral parotid and submandibular glands on oral health in the management of sialorrhea. Twenty children diagnosed with cerebral palsy were randomly assigned to 2 groups. The treatment group received botulinum toxin type A injections, whereas the control received normal saline in the same locations. The authors evaluated subjective drooling scales, salivary flow rate, and oral health (salivary compositions and cariogenic bacterial counts). A significant decrease was found in salivary flow rate at the 1- and 3-month follow-up in the botulinum toxin—treated group. The authors suggest that current protocol can effectively manage sialorrhea while maintaining oral health.
van der Burg J., Jongerius PH, van Limbeek J., et al. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr. 2006 ;165:37-41.
2.
Tahmassebi JF , Curzon ME, Curzon MEJ.Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol . 2003;45(9):613-617.
3.
Jongerius PH , van den Hoogen FJ, van Limbeek J., et al. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004;114(3):620-627.
4.
Bothwell JE , Clarke K., Dooley JM, et al. Botulinum toxin A as a treatment for excessive drooling in children . Pediatr Neurol. 2002;27(1):18-22.
5.
Cotton RT, Richardson MAThe effect of submandibular duct rerouting in the treatment of sialorrhea in children. Otolaryngol Head Neck Surg. 1981 ;89(4):535-541.
6.
Pal PK, Calne DB, Calne S., Tsui JKBotulinum toxin A as treatment for drooling saliva in PD. Neurology. 2000;54(1): 244-247.
7.
Tan EKBotulinum toxin treatment of sialorrhea: comparing different therapeutic preparations . Eur J Neurol. 2006;13(suppl 1): 60-64.
8.
Wu KP, Ke J-Y., Chung C-Y., et al. Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan. Chang Gung Med J. 2008;31(3):281-286.
9.
Gopinath VK, Arzreanne ARSaliva as a diagnostic tool for assessment of dental caries. Arch Orofac Sci. 2006;1:57-59.
10.
Bardow A., Nyvad B., Nauntofte B.Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ . Arch Oral Biol. 2001;46(5):413-423.
11.
Farsi N.Dental caries in relation to salivary factors in Saudi population groups. J Contemp Dent Pract. 2008;9(3):16-23.
12.
Brambilla E. , Twetman S., Felloni A., et al. Salivary mutans streptococci and lactobacilli in 9- and 13-year-old Italian schoolchildren and the relation to oral health . Clin Oral Investig. 1999; 3(1):7-10.
13.
Zhang Q., Bian Z., Fan M., van Palenstein Helderman WHSalivary mutans streptococci counts as indicators in caries risk assessment in 6-7-year-old Chinese children. J Dent. 2007; 35(2):177-180.
14.
Gabris K., Nyarasdy I., Banoczy J., et al. Significance of assessing risk factors for caries in their prevention . Orvosi Hetilap. 2002; 143(24):1467-1473.
15.
Oncag O., Alpoz AR, Eronat C. Salivary.Streptococcus mutans. lactobacilli levels and buffer capacity in children with esophageal burns. J Clin Pediatr Dent. 2000;24(2):147-151.
16.
Lin Y.-C. , Lin I.-L, Chiu Y.-T, Shieh J.-Y. Botulinum toxin type A treatment for drooling in Taiwanese children with cerebral palsy: three case reports. Tw J Phys Med. 2007;35(3):165-170.
17.
Wilken B., Aslami B., Backes H.Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics. 2008 ;39(4):200-204.
18.
Alrefai AH, Aburahma SK, Khader YSTreatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial. Clin Neurol Neurosurg.2009 ;111(1):79-82.
19.
Vaile L., Finlay F.Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy? Arch Dis Child . 2006;91(10):862-863.
20.
Hassin-Baer S., Scheuer E., Buchman AS, et al. Botulinum toxin injections for children with excessive drooling. J Child Neurol . 2005 ;20(2):120-123.
21.
Banerjee KJ , Glasson C., O’Flaherty SJParotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy . Dev Med Child Neurol. 2006;48(11): 883-887.
22.
Sriskandan N., Moody A., Howlett DCUltrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy. Br J Oral Maxillofac Surg.2010;48(1):58-60.
23.
Hopewell S. , Clarke M., Moher D., et al. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371(9609):281-283.
24.
Palisano R. , Rosenbaum P., Walter S., et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997 ; 39(4):214-223.
25.
Ellies M., Laskawi R., Rohrbach-Volland S., et al. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg. 2003; 61(4):454-457.
26.
Moller E., Karlsborg M., Bardow A., et al. Botulinum toxin into salivary glands-salivary flow and composition . http://iadr.confex.com/iadr/2004Hawaii/techprogram/abstract_44904.htm .
27.
Kim H., Lee Y., Weiner D., et al. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil. 2006;87(1):141-144.
28.
Jongerius PH , Rotteveel JJ, van Limbeek J., et al. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004;63(8):1371-1375.
29.
Suskind DL, Tilton A., Suskind DL, Tilton A.Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112(1):73-81.
30.
Ellies M., Laskawi R., Rohrbach-Volland S., et al. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope. 2002; 112(1):82-86.
31.
Fuster Torres MA, Berini Aytes L., Gay Escoda C., et al. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12(7): E511-E517.
32.
Jongerius PH , Rotteveel JJ, van den Hoogen F., et al. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy . Presentation of a case series. Eur J Pediatr . 2001;160(8):509-512.
33.
Lin YC, Shieh JY, Cheng ML, et al. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology. 2008;70(4):316-318.
